Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Michael T Heneka; Róisín M McManus; Eicke Latz

doi:10.1038/s41583-019-0137-1

Author Correction: Inflammasome signalling in brain function and neurodegenerative disease

Nat Rev Neurosci. 2019 Mar;20(3):187. doi: 10.1038/s41583-019-0137-1.

Authors

Michael T Heneka^{1

2

3}, Róisín M McManus^{4

5}, Eicke Latz^{5

6

7}

Affiliations

¹ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany. michael.heneka@ukbonn.de.
² German Center for Neurodegenerative Diseases, Bonn, Germany. michael.heneka@ukbonn.de.
³ Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA. michael.heneka@ukbonn.de.
⁴ Department of Neurodegenerative Disease and Geriatric Psychiatry, University of Bonn, Bonn, Germany.
⁵ German Center for Neurodegenerative Diseases, Bonn, Germany.
⁶ Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, MA, USA.
⁷ Institute of Innate Immunity, University of Bonn, Bonn, Germany.

PMID: 30742056
DOI: 10.1038/s41583-019-0137-1

Abstract

In the originally published version of this article, the competing interests statement indicated that the authors had no competing interests; however, this statement was incorrect. The statement should have read as follows: 'M.H. receives a consultation fee from IFM Therapeutics, LLC for consultations regarding the pathogenesis and interventional strategies of neurodegenerative disease. E.L. is a scientific co-founder and consultant to IFM Therapeutics. R.M.M. declares no competing interests.' This error has been corrected in the HTML and PDF versions of the article.

Publication types

Published Erratum